Stephen Hoge, President at Moderna, Inc. (MRNA), sold 80,575 shares at $144.13 ($11.7M) on 2026-09-14, disclosed to the SEC on 2026-09-16.
Scheduled sale ($11.7M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $144.13 | 40,294 | $5.8M | 49.7% |
| 2 | $146.07 | 40,281 | $5.9M | 50.3% |
| Total | $145.10 avg | 80,575 | $11.7M | 100% |
| Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |
| MRNA | SELL | 2024-12-04 | $14K | — | Filing → |